Some trials report significantly reduced oxidative markers versus a control group, though results vary by dose, route, and baseline levels
In reality, Ozempic isnt actually a weight loss drug, or at least thats not its intended purpose
*Correspondence: Baptist Gallwitz, [email protected] This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
But with alcohol consumption hitting record lows, the home bar is less and less of a design default
Results may vary, with continued benefits building over time
Inflammopharmacology 33, 845864